Low-molecular weight heparin as prophylaxis against thromboembolism after total hip replacement—is it worth the price?

By Persson Björn M  

Acta Orthopaedica Scandinavica, Vol. 71, Iss. 2, 2000-04 ,pp. : 215-216

Informa Healthcare

Access to resources Recommend Favorite

Venous Thromboembolism Prophylaxis after Head and Spinal Trauma: Intermittent Pneumatic Compression Devices Versus Low Molecular Weight Heparin

By Kurtoglu Mehmet  

World Journal of Surgery, Vol. 28, Iss. 8, 2004-08 ,pp. : 807-811

Springer Publishing Company

Access to resources Recommend Favorite

Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital

By Dahl Ola   Gudmundsen Tor   Bjørnarå Bård   Solheim Dag  

Acta Orthopaedica Scandinavica, Vol. 74, Iss. 3, 2003-01 ,pp. : 299-304

Informa Healthcare

Access to resources Recommend Favorite

Prophylaxis of Venous Thromboembolism Using Two Different Doses of Low-Molecular-Weight Heparin (Nadroparin) in Bariatric Surgery: A Prospective Randomized Trial

By Yarmenitis Spyros   Kehagias Ioannis   Karamesini Maria   Dimitrakopoulos Athanasios   Maniati Aliki   Stavropoulou Fotini   Kalfarentzos Fotis  

Obesity Surgery, Vol. 11, Iss. 6, 2001-12 ,pp. : 670-676

Springer Publishing Company

Access to resources Recommend Favorite

Utility of Once-Daily Dose of Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Multisystem Trauma Patients

By Cothren C.   Smith Wade   Moore Ernest   Morgan Steven  

World Journal of Surgery, Vol. 31, Iss. 1, 2007-01 ,pp. : 98-104

Springer Publishing Company

Access to resources Recommend Favorite